A phase 2b/3 Randomized Clinical Trial of Clazakizumab in Patients with End Stage Kidney Disease Undergoing Dialysis
Clinical Trial Grant
Administered By
Duke Clinical Research Institute
Awarded By
CSL Behring LLC
Start Date
March 28, 2022
End Date
June 30, 2024
Administered By
Duke Clinical Research Institute
Awarded By
CSL Behring LLC
Start Date
March 28, 2022
End Date
June 30, 2024